Myasthenia Gravis Therapy with Individualized Homeopathy: A Case Report

Overview

Journal Clin Case Rep

Date 2020 Dec 28

PMID 33363760

Citations 2

Authors

Vitalie Vacaras

Cristina Nistor

Imelda Rahovan

Cristiana Vacaras

George Vithoulkas

Affiliations

Soon will be listed here.

Abstract

We present a 61-year-old man with severe myasthenia gravis, nonresponsive to conventional therapy. The patient was treated with individualized homeopathy, demonstrating significant improvement on his clinical status and no disease symptoms.

Citing Articles

An integrated perspective on transmutation of acute inflammation into chronic and the role of the microbiome.

Vithoulkas G J Med Life. 2022; 14(6):740-747.

PMID: 35126742 PMC: 8811668. DOI: 10.25122/jml-2021-0375.

Myasthenia gravis therapy with individualized homeopathy: A case report.

Vacaras V, Nistor C, Rahovan I, Vacaras C, Vithoulkas G Clin Case Rep. 2020; 8(12):2464-2468.

PMID: 33363760 PMC: 7752385. DOI: 10.1002/ccr3.3190.

References

Chikramane P, Suresh A, Bellare J, Kane S . Extreme homeopathic dilutions retain starting materials: A nanoparticulate perspective. Homeopathy. 2010; 99(4):231-42. DOI: 10.1016/j.homp.2010.05.006. View

Carr A, Cardwell C, McCarron P, McConville J . A systematic review of population based epidemiological studies in Myasthenia Gravis. BMC Neurol. 2010; 10:46. PMC: 2905354. DOI: 10.1186/1471-2377-10-46. View

Gilhus N . Myasthenia Gravis. N Engl J Med. 2016; 375(26):2570-2581. DOI: 10.1056/NEJMra1602678. View

Juel V . Repetitive nerve stimulation testing in myasthenic crisis. Muscle Nerve. 2019; 59(5):528-530. DOI: 10.1002/mus.26472. View

Smith S, Lee A . Update on Ocular Myasthenia Gravis. Neurol Clin. 2016; 35(1):115-123. DOI: 10.1016/j.ncl.2016.08.008. View

Boldingh M, Maniaol A, Brunborg C, Weedon-Fekjaer H, Verschuuren J, Tallaksen C . Increased risk for clinical onset of myasthenia gravis during the postpartum period. Neurology. 2016; 87(20):2139-2145. PMC: 5109939. DOI: 10.1212/WNL.0000000000003339. View

Vacaras V, Nistor C, Rahovan I, Vacaras C, Vithoulkas G . Myasthenia gravis therapy with individualized homeopathy: A case report. Clin Case Rep. 2020; 8(12):2464-2468. PMC: 7752385. DOI: 10.1002/ccr3.3190. View

McConville J, Farrugia M, Beeson D, Kishore U, Metcalfe R, Newsom-Davis J . Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann Neurol. 2004; 55(4):580-4. DOI: 10.1002/ana.20061. View

Silvestri N, Wolfe G . Treatment-refractory myasthenia gravis. J Clin Neuromuscul Dis. 2014; 15(4):167-78. DOI: 10.1097/CND.0000000000000034. View

10.

Chan K, Lachance D, Harper C, Lennon V . Frequency of seronegativity in adult-acquired generalized myasthenia gravis. Muscle Nerve. 2007; 36(5):651-8. DOI: 10.1002/mus.20854. View

11.

Hehir M, Silvestri N . Generalized Myasthenia Gravis: Classification, Clinical Presentation, Natural History, and Epidemiology. Neurol Clin. 2018; 36(2):253-260. DOI: 10.1016/j.ncl.2018.01.002. View

12.

Jayam Trouth A, Dabi A, Solieman N, Kurukumbi M, Kalyanam J . Myasthenia gravis: a review. Autoimmune Dis. 2012; 2012:874680. PMC: 3501798. DOI: 10.1155/2012/874680. View

13.

Godoy D, Jardim Vaz de Mello L, Masotti L, Di Napoli M . The myasthenic patient in crisis: an update of the management in Neurointensive Care Unit. Arq Neuropsiquiatr. 2013; 71(9A):627-39. DOI: 10.1590/0004-282X20130108. View

14.

Conti-Fine B, Milani M, Kaminski H . Myasthenia gravis: past, present, and future. J Clin Invest. 2006; 116(11):2843-54. PMC: 1626141. DOI: 10.1172/JCI29894. View

15.

Farmakidis C, Pasnoor M, Dimachkie M, Barohn R . Treatment of Myasthenia Gravis. Neurol Clin. 2018; 36(2):311-337. PMC: 6690491. DOI: 10.1016/j.ncl.2018.01.011. View